Annals of Oncology View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1990

PUBLISHER

Springer Netherlands

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/10478

Recent publications latest 20 shown

  • 1999-09 Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer
  • 1999-09 p53 and chemosensitivity
  • 1999-09 The clinical utility of the Revised European-American Lymphoma (R.E.A.L.) Classification: Preliminary results of a prospective study in patients with non-Hodgkin's lymphoma from a single centre
  • 1999-09 Phase I study of Doxil and vinorelbine in metastatic breast cancer
  • 1999-09 Recurrent inflammation in a site of previous necrotising fasciitis during intravenous CMF chemotherapy
  • 1999-09 Factors associated with tumor volume and primary metastases in Ewing tumors: Results from the (EI)CESS studies
  • 1999-09 High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study
  • 1999-09-01 CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial
  • 1999-09 Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer
  • 1999-09 Life threatening laryngeal toxicity following treatment with combined chemoradiotherapy for nasopharyngeal cancer: A case report with review of the literature
  • 1999-09 Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience
  • 1999-09-01 Complete response of a gastric primary after a short but toxic course of ‘S-1’
  • 1999-05 Chemotherapy in carcinomas of unknown primary site: A high-dose intensity policy
  • 1999-05-01 Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study
  • 1999-05 ESHAP is an active regimen for relapsing Hodgkin's disease
  • 1999-05 Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
  • 1999-05 Dose-escalation of CHOP in non-Hodgkin's lymphoma
  • 1999-05 Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
  • 1999-05 High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234
  • 1999-05 Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia
  • Subjects

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }
        ], 
        "alternateName": "Official Journal of the European Society for Medical Oncology", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "3.46", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "5.599", 
            "type": "Rating"
          }
        ], 
        "id": "sg:journal.1100417", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "issn": [
          "0923-7534", 
          "1569-8041"
        ], 
        "license": "Hybrid (Open Choice)", 
        "name": "Annals of Oncology", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "100417"
            ]
          }, 
          {
            "name": "springer_id", 
            "type": "PropertyValue", 
            "value": [
              "10478"
            ]
          }, 
          {
            "name": "lccn_id", 
            "type": "PropertyValue", 
            "value": [
              "sn 90031231"
            ]
          }, 
          {
            "name": "wos_id", 
            "type": "PropertyValue", 
            "value": [
              "0923-7534/ANNALS OF ONCOLOGY"
            ]
          }, 
          {
            "name": "scopus_id", 
            "type": "PropertyValue", 
            "value": [
              "28711"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "9007735"
            ]
          }, 
          {
            "name": "nsd_ids_id", 
            "type": "PropertyValue", 
            "value": [
              "340016"
            ]
          }, 
          {
            "name": "era_ids_id", 
            "type": "PropertyValue", 
            "value": [
              "15686"
            ]
          }
        ], 
        "publisher": {
          "name": "Springer Netherlands", 
          "type": "Organization"
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1100417"
        ], 
        "sdDataset": "journals", 
        "sdDatePublished": "2021-01-19T05:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", 
        "startYear": "1990", 
        "type": "Periodical", 
        "url": "http://link.springer.com/journal/10478"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1100417'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1100417'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1100417'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1100417'


     

    This table displays all metadata directly associated to this object as RDF triples.

    69 TRIPLES      19 PREDICATES      29 URIs      24 LITERALS      12 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1100417 schema:about sg:ontologies/product-market-codes/H33160
    2 schema:alternateName Official Journal of the European Society for Medical Oncology
    3 schema:contentRating Nd5662106f85e4d039cbbfa101aaed221
    4 Ndf9eecd6bbde4dbdaa7fe0b502a6921c
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:issn 0923-7534
    8 1569-8041
    9 schema:license Hybrid (Open Choice)
    10 schema:name Annals of Oncology
    11 schema:productId N4f7b2f5f75d545e9a8af6bd7da67d945
    12 N671eaf0d1a0a493582784cf25ab9a2a9
    13 N6bb320008ec84e81a79f138bdebb4fb1
    14 N6c926d82cc5c48a2acdfc40d8a9bec7f
    15 N9ad0eb7de3c945cbaa82f8e9ffa41c73
    16 Nb6f42627d1e3454db827e26e639293b1
    17 Nbca253eecac34b2f861a0fac32834d0f
    18 Nfc44464846d64027ad2317b46bbca0e8
    19 schema:publisher N61d3470e7aed4cf1bfa66e8f07aad009
    20 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1100417
    21 schema:sdDatePublished 2021-01-19T05:00
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher Ne997e1ac1ad04938b273a7af8f6ab421
    24 schema:startYear 1990
    25 schema:url http://link.springer.com/journal/10478
    26 sgo:license sg:explorer/license/
    27 sgo:sdDataset journals
    28 rdf:type schema:Periodical
    29 N2f3da2082aeb413fa8528adec434bded rdf:first snip
    30 rdf:rest rdf:nil
    31 N4f7b2f5f75d545e9a8af6bd7da67d945 schema:name dimensions_id
    32 schema:value 100417
    33 rdf:type schema:PropertyValue
    34 N61d3470e7aed4cf1bfa66e8f07aad009 schema:name Springer Netherlands
    35 rdf:type schema:Organization
    36 N671eaf0d1a0a493582784cf25ab9a2a9 schema:name nsd_ids_id
    37 schema:value 340016
    38 rdf:type schema:PropertyValue
    39 N6bb320008ec84e81a79f138bdebb4fb1 schema:name wos_id
    40 schema:value 0923-7534/ANNALS OF ONCOLOGY
    41 rdf:type schema:PropertyValue
    42 N6c926d82cc5c48a2acdfc40d8a9bec7f schema:name springer_id
    43 schema:value 10478
    44 rdf:type schema:PropertyValue
    45 N9ad0eb7de3c945cbaa82f8e9ffa41c73 schema:name lccn_id
    46 schema:value sn 90031231
    47 rdf:type schema:PropertyValue
    48 Nb6f42627d1e3454db827e26e639293b1 schema:name era_ids_id
    49 schema:value 15686
    50 rdf:type schema:PropertyValue
    51 Nbca253eecac34b2f861a0fac32834d0f schema:name nlm_unique_id
    52 schema:value 9007735
    53 rdf:type schema:PropertyValue
    54 Nd5662106f85e4d039cbbfa101aaed221 schema:author N2f3da2082aeb413fa8528adec434bded
    55 schema:ratingValue 3.46
    56 rdf:type schema:Rating
    57 Ndf9eecd6bbde4dbdaa7fe0b502a6921c schema:author Nffabd472fce9444bb78c88c12c8d87c5
    58 schema:ratingValue 5.599
    59 rdf:type schema:Rating
    60 Ne997e1ac1ad04938b273a7af8f6ab421 schema:name Springer Nature - SN SciGraph project
    61 rdf:type schema:Organization
    62 Nfc44464846d64027ad2317b46bbca0e8 schema:name scopus_id
    63 schema:value 28711
    64 rdf:type schema:PropertyValue
    65 Nffabd472fce9444bb78c88c12c8d87c5 rdf:first sjr
    66 rdf:rest rdf:nil
    67 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    68 schema:name Oncology
    69 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...